Medica device firm Encisione says Q3 sales hit by robot competition, to restructure to cut costs

Encision

04/02/2026 12:14

Overview

Medical device company's fiscal Q3 revenue fell 7.5% due to competition from surgical robots

Gross profit margin decreased significantly due to a large increase to the inventory reserve

Company is restructuring to reduce operating expenses, impact expected in Q4

Outlook

Encision expects revenue decrease to continue due to robotic surgeries replacing its procedures

Company restructuring to reduce operating expenses will impact fourth-quarter results

Result Drivers

SURGICAL ROBOTS - Revenue decline attributed to procedures performed by surgical robots replacing company procedures, per CEO Robert Fries

INVENTORY RESERVE - Gross profit margin decreased significantly due to a large increase to the inventory reserve

RESTRUCTURING - Company is restructuring and has reduced operating expenses substantially, impact expected in Q4

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Product Revenue
$1.41 mln
Q3 Gross Profit
$543,000
Q3 Operating Expenses
$842,000
Q3 Operating Income
-$299,000


Press Release: ID:nACSJZSpza

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)